SEVION THERAPEUTICS INC

Inactive Instrument

Analyst Reco. Sevion Therapeutics Inc OTC Bulletin Board

Equities

US81834Q1040

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Apr. 11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ
Mar. 13	Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $30 From $60, Maintains Outperform Rating	Nov. 02	MT
Oppenheimer Raises Eloxx Pharmaceuticals Price Target to $60 From $55, Maintains Outperform Rating	23-09-14	MT
Oppenheimer Adjusts Eloxx Pharmaceuticals' Price Target to $55 From $50, Keeps Outperform Rating	23-07-11	MT
Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $50 From $3, Maintains Outperform Rating	23-01-05	MT
Piper Sandler Adjusts Eloxx Pharmaceuticals' Price Target to $1.50 from $4, Keeps Overweight Rating	22-05-23	MT
HC Wainwright Trims Eloxx Pharmaceuticals Price Target to $0.5 From $1, Maintains Neutral Rating	22-05-09	MT
B. Riley Lowers Eloxx Pharmaceuticals' Price Target to $3 from $5 After Revising Cost Capital Assumptions, Keeps Buy Rating	22-01-24	MT
Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Price Target	21-12-17	MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral Rating	21-11-18	MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neutral Rating	21-11-11	MT
ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 Price Target	21-06-30	MT
ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Compelling Turnaround Story	21-05-27	MT
ELOXX PHARMACEUTICALS : Piper Sandler Adjusts Price Target on Eloxx Pharmaceuticals to $4 From $6, Keeps Overweight Rating	21-05-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer